Latest Articles

Publication Date
Silent but Destructive: Ureteral Deep Infiltrating Endometriosis Progressing to Renal Injury - A Case Report.

Ureteral endometriosis is a rare form of deep infiltrating endometriosis that may lead to silent ureteral obstruction and progressive renal injury. Early diagnosis remains challenging because symptoms are often nonspecific.

Published: June 18, 2026, midnight
Endometrial dysfunction in embryo implantation: from molecular mechanisms to clinical management.

Endometrial dysfunction represents a central pathological factor underlying recurrent implantation failure and infertility. This review provides a comprehensive synthesis of the physiological basis of endometrial function, the pathological factors compromising …

Published: June 18, 2026, midnight
Case Report: Malignant transformation of deep infiltrating endometriosis: a report of two cases and literature review.

Deep infiltrating endometriosis (DIE) is a severe form of endometriosis that rarely undergoes malignant transformation, and when it does, diagnosis is often difficult. Here, we report two cases of long-standing …

Published: June 18, 2026, midnight
Bliss IVF Highlights Fertility Success Through Twin Birth in Advanced Endometriosis Case - First India

Bliss IVF Highlights Fertility Success Through Twin Birth in Advanced Endometriosis Case First India

Published: June 17, 2026, 1:57 p.m.
Bliss IVF Highlights Fertility Success Through Twin Birth In Advanced Endometriosis Case - outlookbusiness.com

Bliss IVF Highlights Fertility Success Through Twin Birth In Advanced Endometriosis Case outlookbusiness.com

Published: June 17, 2026, 1:44 p.m.
Bliss IVF Highlights Fertility Success Through Twin Birth in Advanced Endometriosis Case - NewsX

Bliss IVF Highlights Fertility Success Through Twin Birth in Advanced Endometriosis Case NewsX

Published: June 17, 2026, 1:06 p.m.
Leerink’s AI Pipeline Focus and Jones AI Day Spotlight Might Change The Case For Investing In Absci (ABSI) - simplywall.st

Leerink’s AI Pipeline Focus and Jones AI Day Spotlight Might Change The Case For Investing In Absci (ABSI) simplywall.st

Published: June 17, 2026, 9:33 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - beQuoted

Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat beQuoted

Published: June 17, 2026, 9 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - The Manila Times

Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat The Manila Times

Published: June 17, 2026, 8:29 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - Yahoo Finance Singapore

Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat Yahoo Finance Singapore

Published: June 17, 2026, 8:05 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!